Genetic Disorders and the Fetus. Группа авторов
amniotic fluid. PLoS One 2012; 7:e47642.
398 398. Evaldson G, Nord CE. Amniotic fluid activity against Bacteroides fragilis and group B streptococci. Med Microbiol Immunol 1981; 170:11.
399 399. Ismail MA, Salti GI, Moawad AH. Effect of amniotic fluid on bacterial recovery and growth: clinical implications. Obstet Gynecol Surv 1989; 44:571.
400 400. Martius J, Eschenbach DA. The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity – a review. Arch Gynecol Obstet 1990; 247:1.
401 401. Farzin A, Boyer P, Ank B, et al. Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro. AIDS Res Hum Retroviruses 2013; 29:77.
402 402. Charles D, Edwards WR. Infectious complications of cervical cerclage. Am J Obstet Gynecol 1981; 141:1065.
403 403. Lebon P, Girard S, Thepot F, et al. Embryologie générale: présence constante d'interféron de type a dans les liquides amniotiques humains. C R Hebd Seances Acad Sci Paris 1981; 293:69.
404 404. Morgan‐Capner P, Rodeck CH, Nicolaides KH, et al. Prenatal detection of rubella‐specific IgM in fetal sera. Prenat Diagn 1985; 5:21.
405 405. Ho‐Terry L, Terry GM, Londesborough P. Diagnosis of foetal rubella virus infection by polymerase chain reaction. J Gen Virol 1990; 71 (Pt 7):1607.
406 406. Bosma TJ, Corbett KM, Eckstein MB, et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 1995; 33:2881.
407 407. Combs CA, Gravett M, Garite TJ, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014; 210:125 e1.
408 408. Ardissone AN, de la Cruz DM, Davis‐Richardson AG, et al. Meconium microbiome analysis identifies bacteria correlated with premature birth. PLoS One 2014; 9:e90784.
409 409. Pons JC, Vial P, Rozenberg F, et al. Diagnostic prenatal de la foetopathie varicelleuse au deuxi`eme trimester de la grossesse. [Prenatal diagnosis of fetal varicella in the second trimester of pregnancy]. J Gynecol Obstet Biol Reprod (Paris) 1995; 24:829.
410 410. Dufour P, de Bievre P, Vinatier D, et al. Varicella and pregnancy. Eur J Obstet Gynecol Reprod Biol 1996; 66:119.
411 411. Shukla SK, Meier PR, Mitchell PD, et al. Leptotrichia amnionii sp. nov., a novel bacterium isolated from the amniotic fluid of a woman after intrauterine fetal demise. J Clin Microbiol 2002; 40:3346.
412 412. Blanco JD, Gibbs RS, Krebs LF, et al. The association between the absence of amniotic fluid bacterial inhibitory activity and intra‐amniotic infection. Am J Obstet Gynecol 1982; 143:749.
413 413. Grose C, Weiner CP. Prenatal diagnosis of congenital cytomegalovirus infection: two decades later. Am J Obstet Gynecol 1990; 163:447.
414 414. Derouin F, Thulliez P, Candolfi E, et al. Early prenatal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture. Eur J Clin Microbiol Infect Dis 1988; 7:423.
415 415. Leiberman JR, Hagay ZJ, Dagan R. Intraamniotic Haemophilus influenzae infection. Arch Gynecol Obstet 1989; 244:183.
416 416. Zauli DA, de Menezes CL, de Oliveira CL. Development and padronization of three multiplex PCRs for the diagnosis of Chlamydia trachomatis, Toxoplasma gondii, herpes simplex viruses 1 and 2, and cytomegalovirus. Mol Biotechnol 2013; 54:1004.
417 417. Curtin WM, Menegus MA, Patru MM, et al. Midtrimester fetal herpes simplex‐2 diagnosis by serology, culture and quantitative polymerase chain reaction. Fetal Diagn Ther 2013; 33:133.
418 418. Czader M, Post K, Cheng L. Detection of cytomegalovirus infection by quantitative polymerase chain reaction. Methods Mol Biol 2013; 999:257.
419 419. Bourgeois‐Nicolaos N, Cordier AG, Guillet‐Caruba C, et al. Evaluation of the Cepheid Xpert GBS assay for rapid detection of group B streptococci in amniotic fluids from pregnant women with premature rupture of membranes. J Clin Microbiol 2013; 51:1305.
420 420. Bernard B, Barton L, Abate M, et al. Maternal–fetal transfer of cefazolin in the first twenty weeks of pregnancy. J Infect Dis 1977; 136:377.
421 421. Giamarellou H, Gazis J, Petrikkos G, et al. A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy. Am J Obstet Gynecol 1983; 147:914.
422 422. Allegaert K, van Mieghem T, Verbesselt R, et al. Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy. Am J Obstet Gynecol 2009; 200:170 e1.
423 423. Atkinson G, Campbell DJ, Cawood ML, et al. Steroids in human intrauterine fluids of early pregnancy. Clin Endocrinol (Oxf) 1996; 44:435.
424 424. Nakanishi T, Suzumori N, Mizuno H, et al. Elevated aldosterone in amniotic fluid and maternal blood has diagnostic potential in pregnancies complicated with a fetus of Bartter syndrome. Fetal Diagn Ther 2005; 20:481.
425 425. Mennuti MT, Wu CH, Mellman WJ, et al. Amniotic fluid testosterone and follicle stimulating hormone levels as indicators of fetal sex during mid‐pregnancy. Am J Med Genet 1977; 1:211.
426 426. Wisniewski L, Jezuita J, Bogoniowska Z, et al. Endokrynologia prenatalna. I. Kortyzol w plynie owodniowym i w surowicy krwi kobiet w 17 tygodniu ciazy [Prenatal endocrinology. II. Growth hormone in the amniotic fluid and blood serum of women in the 17th week of pregnancy]. Ginekol Pol 1983; 54:693.
427 427. Goebelsmann U, Abboud TK, Hoffman DI, et al. Beta endorphin in pregnancy. Eur J Obstet Gynecol Reprod Biol 1984; 17:77.
428 428. Teramo K, Kari MA, Eronen M, et al. High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia 2004; 47:1695.
429 429. Freeman R, Lev‐Gur M, Koslowe R, et al. Maternal plasma and amniotic fluid levels of estradiol, estrone, progesterone, and prolactin in early pregnancy. Obstet Gynecol 1984; 63:507.
430 430. Sugar J, Dessy C, Alexander S, et al. Estriol‐3‐glucuronide and estriol‐16‐glucuronide in amniotic fluid during normal pregnancy. J Clin Endocrinol Metab 1980; 50:137.
431 431. Zamlynski J, Chudek J, Olejek A, et al. Galanin concentrations in maternal circulation, amniotic fluid and umbilical cord blood during term labor: relationship with maternal body mass and neonatal birth weight. Gynecol Endocrinol 2007; 23:295.
432 432. Heikinheimo M, Seppala M, Brock DJ. Pregnancy specific beta 1‐glycoprotein and human chorionic gonadotrophin levels in amniotic fluid and maternal serum in the first half of pregnancy. Oncodev Biol Med 1980; 1:71.
433 433. Dattatreyamurty B, Sheth AR, Purandare TV, et al. Gonadotrophins during second trimester of pregnancy: I. LH and hCG levels in maternal serum and amniotic fluid and their relationship to the sex of the foetus. Acta Endocrinol (Copenh) 1979; 91:692.
434 434. Buhling KJ, Monnich J, Henrich W, et al. Zusammenhang zwischen Fruchtwasserinsulin im zweiten Trimenon, mutterlicher Glukosetoleranz und fetalen Fehlbildungen [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetalmalformations]. Z Geburtshilfe Neonatol 2004; 208:226.
435 435. Tisi DK, Liu XJ, Wykes LJ, et al. Insulin‐like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated with infant birth weight. J Nutr 2005; 135:1667.
436 436. Bay K, Cohen AS, Jorgensen FS, et al. Insulin‐like factor 3 levels in second‐trimester amniotic fluid. J Clin Endocrinol Metab 2008; 93:4048.
437 437. D'Anna R, Baviera G, Cannata ML, et al. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes. Gynecol Obstet Invest 2007; 64:65.
438 438. Marek S, Bock K, Hellmeyer L, et al. Herkunft und Bedeutung von Leptin und Neuropeptid Y (NPY) im Fruchtwasser zwischen der 14.‐ 18. Schwangerschaftswoche [Origin and significance of leptin and neuropeptide Y (NPY) in amniotic fluid between the 14th and 18th weeks of gestation]. Z Geburtshilfe Neonatol 2006; 210:208.
439 439. Petrucha RA, Goebelsmann U, Hung TT, et al. Amniotic fluid beta‐endorphin and beta‐lipotropin concentrations